Operating Income (Loss) in USD of Teladoc Health, Inc. from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Teladoc Health, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2013 to Q3 2025.
  • Teladoc Health, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$52M, a 17% decline year-over-year.
  • Teladoc Health, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$275M, a 72.7% increase year-over-year.
  • Teladoc Health, Inc. annual Operating Income (Loss) for 2024 was -$1.02B, a 311% decline from 2023.
  • Teladoc Health, Inc. annual Operating Income (Loss) for 2023 was -$249M.
  • Teladoc Health, Inc. annual Operating Income (Loss) for 2022 was -$13.7B.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Teladoc Health, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$275M -$52M -$7.56M -17% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$268M -$54.4M +$787M +93.5% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 -$1.05B -$121M -$33.5M -38.4% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 -$1.02B -$48.2M -$13.1M -37.4% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 -$1.01B -$44.4M +$20.3M +31.4% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$1.03B -$841M -$770M -1074% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 -$259M -$87.1M -$10M -13% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 -$249M -$35.1M 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 -$64.7M +$7.01M +9.77% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 -$71.6M +$3.02B +97.7% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024
Q1 2023 -$77.1M +$6.59B +98.8% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024
Q3 2022 -$9.88B -$71.7M -$11.2M -18.4% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 -$9.87B -$3.1B -$3.02B -3822% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023
Q1 2022 -$6.85B -$6.67B -$6.58B -7776% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 -$266M -$41.4M +$417M +91% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024
Q3 2021 -$683M -$60.6M -$40.9M -207% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$642M -$78.9M -$71.8M -1000% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$570M -$84.7M -$63.7M -303% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022
Q4 2020 -$506M -$459M -$443M -2841% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023
Q3 2020 -$63.5M -$19.7M +$219K +1.1% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 -$63.7M -$7.18M +$14.8M +67.4% 01 Apr 2020 30 Jun 2020 10-Q 02 Aug 2021
Q1 2020 -$78.6M -$21M +$1.88M +8.2% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021
Q4 2019 -$80.4M -$15.6M +$2.25M +12.6% 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2020
Q3 2019 -$82.7M -$19.9M -$4.17M -26.4% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$78.5M -$22M -$3.88M -21.4% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 -$74.6M -$22.9M -$3.8M -19.9% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 -$70.9M -$17.8M +$6.72M +27.4% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2020
Q3 2018 -$77.6M -$15.8M +$5.76M +26.8% 01 Jul 2018 30 Sep 2018 10-K 26 Feb 2020
Q2 2018 -$83.3M -$18.1M -$3.66M -25.2% 01 Apr 2018 30 Jun 2018 10-K 26 Feb 2020
Q1 2018 -$79.7M -$19.1M -$4.29M -29% 01 Jan 2018 31 Mar 2018 10-K 26 Feb 2020
Q4 2017 -$75.4M -$24.6M -$11.3M -85.6% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 -$64.1M -$21.5M -$1.28M -6.34% 01 Jul 2017 30 Sep 2017 10-K 27 Feb 2019
Q2 2017 -$62.8M -$14.5M -$30K -0.21% 01 Apr 2017 30 Jun 2017 10-K 27 Feb 2019
Q1 2017 -$62.8M -$14.8M -$87K -0.59% 01 Jan 2017 31 Mar 2017 10-K 27 Feb 2019
Q4 2016 -$62.7M -$13.2M +$1.12M +7.78% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 -$63.8M -$20.3M -$7.66M -60.8% 01 Jul 2016 30 Sep 2016 10-K 27 Feb 2018
Q2 2016 -$56.1M -$14.5M +$1.79M +11% 01 Apr 2016 30 Jun 2016 10-K 27 Feb 2018
Q1 2016 -$57.9M -$14.7M -$2.12M -16.9% 01 Jan 2016 31 Mar 2016 10-K 27 Feb 2018
Q4 2015 -$55.8M -$14.3M 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018
Q3 2015 -$12.6M -$8.74M -227% 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016
Q2 2015 -$16.3M -$13.4M -469% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016
Q1 2015 -$12.6M 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q3 2014 -$3.86M 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015
Q2 2014 -$2.86M 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015

Teladoc Health, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.02B -$772M -311% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 -$249M +$13.4B 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 -$13.7B* -$13.4B 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 -$266M +$241M +47.5% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 -$506M -$426M -530% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 -$80.4M -$9.59M -13.5% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$70.9M +$4.54M +6.02% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 -$75.4M -$12.7M -20.3% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 -$62.7M -$6.88M -12.3% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 -$55.8M -$40.6M -268% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 -$15.2M -$9.28M -158% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 -$5.87M 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.